Our objective is to present the pharmacological mechanisms, safety profiles, and regulatory status of prominent approved and unapproved peptides marketed direct to patients, including AOD-9604 (anti-obesity drug 9604), BPC-157 (body protection compound 157), CJC-1295, FS-344 (follistatin-344), GHK-Cu (glycyl-l-histidyl-l-lysine copper), ipamorelin, MOTS-C (mitochondrial ORF of the 12S rRNA type-c), sermorelin, SS-31 (elamipretide), tesamorelin (Egrifta), T4 (thymosin beta-4), and TB-500 (thymosin beta-4 fragment)
It can be taken with or without food
If you have severe or persistent skin concerns, please visit a board-certified dermatologist for a personalized treatment plan
To provide the best experiences, we use technologies like cookies to store and/or access device information
In a phase 2 study by Pescovitz et al
The condition affects roughly 1 to 3% of the general adult population, with peak incidence occurring between ages 30 and 50